feed,title,long_url,short_url
MarketWatch,SVB Leerink analyst doesn't expect cancer drug developed by Innovent and Lilly to be approved,http://www.marketwatch.com/news/story/svb-leerink-analyst-doesnt-expect/story.aspx?guid=%7BCA624841%2DBB3F%2D4132%2DAA69%2D08E0275F07E8%7D&siteid=rss,https://on.mktw.net/34ABMI2
